Floatz logo

16 assets in Diffuse Large B-Cell Lymphoma With Chronic Inflammation

Therapeutic assets addressing Diffuse Large B-Cell Lymphoma With Chronic Inflammation, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Adriamycin
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Northwestern UniversityP2/3BB (64)
Prednisone
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Northwestern UniversityP2/3BB (64)
Vincristine Sulfate
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Northwestern UniversityP2/3BB (64)
Cyclophosphamide
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Mayo ClinicP2/3B (63)
Rituximab
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Mayo ClinicP2/3B (63)
Azacitidine
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
National Cancer Institute (NCI)P2/3B (57)
Recombinant Human Hyaluronidase
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
National Cancer Institute (NCI)P2/3B (57)
Golcadomide
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Mayo ClinicP2CCC (53)
Nivolumab
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
National Cancer Institute (NCI)P2CCC (53)
Ontorpacept
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Mayo ClinicP2CCC (53)
Pembrolizumab
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Mayo ClinicP2CCC (53)
Zanubrutinib
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Northwestern UniversityP2CCC (53)
1-118-Signal regulatory protein ? (human) fusion protein with immunoglobulin G4 [128-proline] (human ?4-chain C region C-terminal fragment), dimer
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Mayo ClinicP2CC (45)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
National Cancer Institute (NCI)P2CC (44)
Apamistamab
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Memorial Sloan Kettering Cancer CenterEarly P1C (39)
Synkir-310
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Verismo TherapeuticsP1NR ()